Sepsis Diagnostics Market Worth $1.1 Billion By 2027 | CAGR: 9.4%

February 2020 | Report Format: Electronic (PDF)

Sepsis Diagnostics Market Growth & Trends

The global sepsis diagnostic market size is expected to reach a value of USD 1.1 billion by 2027, expanding at a CAGR of 9.4%, according to a new report by Grand View Research, Inc. High prevalence of sepsis, introduction of technologically advanced medical examination systems and increasing government initiatives is expected to propel market growth over the forecast period.

According to CDC estimates, every year more than 1.7 million adults in U.S. suffer from sepsis, which leads to around 270,000 deaths. Furthermore, according to the report published by OECD in 2018, every year around 3.8 million patients suffer from hospital-acquired infections (HAIs) in acute care hospitals in European countries. High prevalence of HAIs in key regions is expected to significantly increase the demand for medical examination solutions, thereby fueling market growth over the forecast period.

Increasing regulatory approval and introduction of technologically advanced medical examination solutions for the life-threatening disease condition are expected to facilitate market growth over the forecast period. In May 2018, T2 Biosystems, Inc., a U.S.-based emerging medical examination solutions company received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens.

In April 2019, the Scottish Government in collaboration with Sepsis Research (originally called FEAT - The Fiona Elizabeth Agnew Trust) launched a Scotland-wide campaign to spread public awareness about the signs and symptoms of sepsis. Such initiatives to raise public awareness about the disease condition is expected to raise demand for its rapid medical examination solutions and support its market growth in the near future.

 Request a free sample copy or view report summary: Sepsis Diagnostics Market Report

Sepsis Diagnostics Market Report Highlights

  • In 2019, the blood culture media segment has emerged as the largest revenue generating segment owing to the high adoption of culture media tests in laboratories for the diagnosis of septic poisoning

  • Molecular diagnostics is anticipated to witness a lucrative CAGR over the forecast period owing to its high sensitivity, accuracy, and less turnaround time

  • In 2019, bacterial sepsis contributed towards the largest revenue share among the pathogen segment owing to its high prevalence

  • North America dominated the sepsis diagnostics market with the largest revenue share in 2019. High awareness, favorable reimbursement scenario, and presence of established players are facilitating the dominance of this region during the study period

  • The Asia Pacific region is projected to witness a lucrative growth owing to increasing awareness about sepsis diagnosis and treatment in emerging economies such as India and China

  • Some of the key players include bioMérieux SA; Beckman Coulter, Inc.; Becton, Dickinson and Company; Sysmex Corporation; F. Hoffmann-La Roche AG; and Thermo Fisher Scientific, Inc.

Sepsis Diagnostics Market Segmentation

Grand View Research has segmented the global sepsis diagnostics market on the basis of product, technology, pathogen, testing type, and region:

Sepsis Diagnostics Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Instruments

    • Microbiology

    • Molecular Diagnostics

    • Immunoassays

    • Flow Cytometry

  • Blood Culture Media

    • Microbiology

    • Molecular Diagnostics

    • Immunoassays

    • Flow Cytometry

  • Assay Kits and Reagents

    • Microbiology

    • Molecular Diagnostics

    • Immunoassays

    • Flow Cytometry

  • Software

    • Microbiology

    • Molecular Diagnostics

    • Immunoassays

    • Flow Cytometry

Sepsis Diagnostics Technology Outlook (Revenue, USD Million, 2016 - 2027)

  • Microbiology

  • Molecular Diagnostics

  • Immunoassays

  • Flow Cytometry

Sepsis Diagnostics Pathogen Outlook (Revenue, USD Million, 2016 - 2027)

  • Bacterial Sepsis

    • Gram-Positive Bacteria

    • Gram-Negative Bacteria

  • Fungal Sepsis

  • Others

Sepsis Diagnostics Testing Type Outlook (Revenue, USD Million, 2016 - 2027)

  • Laboratory Testing

  • PoC Testing

Sepsis Diagnostics Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • Spain

    • France

    • Italy

    • Russia

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Singapore

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

Request Sample
Request for Customization

Pricing & Purchase Options

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA

Related Market Research